GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » EV-to-Revenue

Pilulka Lekarny AS (XPRA:PINK) EV-to-Revenue : 0.26 (As of Sep. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pilulka Lekarny AS's enterprise value is Kč556 Mil. Pilulka Lekarny AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was Kč2,132 Mil. Therefore, Pilulka Lekarny AS's EV-to-Revenue for today is 0.26.

The historical rank and industry rank for Pilulka Lekarny AS's EV-to-Revenue or its related term are showing as below:

XPRA:PINK' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.18   Med: 0.77   Max: 2.24
Current: 0.26

During the past 6 years, the highest EV-to-Revenue of Pilulka Lekarny AS was 2.24. The lowest was 0.18. And the median was 0.77.

XPRA:PINK's EV-to-Revenue is ranked better than
92.38% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 1.8 vs XPRA:PINK: 0.26

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-22), Pilulka Lekarny AS's stock price is Kč181.00. Pilulka Lekarny AS's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was Kč787.53. Therefore, Pilulka Lekarny AS's PS Ratio for today is 0.23.


Pilulka Lekarny AS EV-to-Revenue Historical Data

The historical data trend for Pilulka Lekarny AS's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pilulka Lekarny AS EV-to-Revenue Chart

Pilulka Lekarny AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - 0.74 1.74 0.70 0.34

Pilulka Lekarny AS Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue Get a 7-Day Free Trial - 0.74 1.74 0.70 0.34

Competitive Comparison of Pilulka Lekarny AS's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's EV-to-Revenue falls into.



Pilulka Lekarny AS EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pilulka Lekarny AS's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=556.123/2131.849
=0.26

Pilulka Lekarny AS's current Enterprise Value is Kč556 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was Kč2,132 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pilulka Lekarny AS  (XPRA:PINK) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pilulka Lekarny AS's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=181.00/787.532
=0.23

Pilulka Lekarny AS's share price for today is Kč181.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was Kč787.53.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pilulka Lekarny AS EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pilulka Lekarny AS Business Description

Traded in Other Exchanges
N/A
Address
Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS Headlines

From GuruFocus

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor 02-02-2023

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-31-2022